Psykey logo

Psykey(OTC) CEOS

Market Cap$1.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2006)-100%
5 Year-90%
1 Year+116%
1 Month+8%
$0.01
+1.85%
+0.00Today
Psykey last closing stock price
MetricPriceDate
Last closeUSD 0.012026-10-13
Psykey stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+24.19%USD 0.002026-10-06
1 month+7.8%USD 0.012026-09-11
3 month-18.33%USD 0.012026-07-15
Year to date+83.33%USD 0.002025-12-31
1 year+115.6%USD 0.002025-10-13
3 year-62.57%USD 0.012023-10-13
5 year-89.77%USD 0.052021-10-14
Since inception-99.93%USD 7.632006-02-14

Psykey Financials at a Glance

Market Cap

$1.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.25M

Net Income (TTM)

-$1.48M

EPS (TTM)

$0.00

P/E Ratio

-1.35

Dividend

$0.00

Beta (Volatility)

0.27 (Low)

Price

$0.01

Volume

2,094

Open

$0.00

Previous Close

$0.01

Daily Range

$0.00 - $0.01

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Aug 18, 2025

CEOS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Psykey

CeCors, Inc. is a company focused on acquiring and developing healthcare businesses that cater to military veterans. The organization operates through two main segments: PsyKey, which deals with consumer goods, particularly coffee products, and VETCOMM, which provides educational resources and services.

Products and Services
  • Consumer goods, primarily coffee products under the PsyKey segment
  • Recurring services including education and resources for veterans through VETCOMM
  • Focus on healthcare solutions tailored for military veterans
Growth Outlook
  • Recent quarterly revenue reached $1,324,840, indicating strong sales growth
  • Operating cash flow improved significantly, showing positive operational efficiency
  • Strategic focus on veteran services positions the company for future expansion
Financial Highlights
  • Trailing twelve months (TTM) revenue of $2,000,000, reflecting a solid revenue base
  • Current ratio of 1.77, indicating good short-term financial health
  • Return on assets at 85.5%, showcasing effective asset utilization
CeCors, Inc. presents a unique investment opportunity within the packaged foods and healthcare sectors. The company's commitment to serving military veterans through tailored products and services positions it favorably in a niche market. Recent financial performance indicates a positive trajectory, with significant revenue growth and improved cash flow metrics. The focus on veteran services not only aligns with social responsibility but also opens avenues for future growth and expansion. Investors may find CeCors, Inc. an intriguing option as it continues to develop its business model and enhance its market presence.
AI Generated • Sep 17, 2026

Industry

Health Care Technology

Sector

Health Care

Employees

125

CEO

Michael Maher

Website

www.cecorsinc.com

Headquarters

Toronto, ON M9W1E8, CA

CEOS Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

733.40%

Return on Capital

-104.63%

Return on Assets

85.50%

Earnings Yield

-74.07%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

313.08M

Volume

2.09K

Avg. Volume

110.04K

Financials (TTM)

Gross Profit

$2.24M

Operating Income

-$833.72K

EBITDA

-$1.33M

Operating Cash Flow

$501.10K

Capital Expenditure

-$121.99K

Free Cash Flow

$379.11K

Cash & ST Invst.

$2.57M

Total Debt

$0.00

Psykey Performance Analysis

Psykey annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 19,316N/A
20232023-12-31USD 419,2992070.7%
20242024-12-31USD 1,827-99.6%
20252025-12-31USD 0N/A
Psykey sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-31103.1%
Q12024-03-31188.0%
Q22024-06-3093.2%
Q12026-03-31N/A
Psykey annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.00100.0%
20232023-12-31USD -0.00185.7%
20242024-12-31USD -0.00-75.0%
20252025-12-31USD 0.01N/A
Psykey sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-31-187.5%
Q12024-03-3169.6%
Q22024-06-3057.1%
Q12026-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$1.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$281.25K

N/A

Employees

6

N/A

Net Income

-$409.90K

-54.1%

EBITDA

-$292.48K

-12.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$2.57M

+2632.5%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

85.50%

N/A

Return on Invested Capital

-1.05%

N/A

Free Cash Flow

-$427.18K

-1310.9%

Operating Cash Flow

-$427.18K

-1269.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HDVYHealth Discovery Corporation
$0.00+9900.00%
HADVHealth Advance Inc.
$0.00+33.33%
NNBPNanobac Pharmaceuticals, Incorporated
$0.00+0.00%
RBIIRising Biosciences, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$221.30-3.16%
BACBank of America
$51.39-4.76%
CRWVCoreWeave
$65.78-15.46%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$110.54-13.35%

Questions About CEOS

What is the current price of Psykey?

Psykey is trading at $0.01 per share.

What is the 52-week range for Psykey?

Over the past 52 weeks, Psykey has traded between $0.00 and $0.01.

How much debt does Psykey have?

As of the most recent reporting period, Psykey reported total debt of $0.00.

How much cash does Psykey have on hand?

Psykey reported $2.57M in cash and cash equivalents in its most recent financial results.

What is Psykey’s dividend yield?

Psykey does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services